Park Avenue Securities’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
+5,920
New +$213K ﹤0.01% 1582
2025
Q3
Sell
-5,717
Closed -$243K 1690
2025
Q2
$243K Buy
+5,717
New +$238K ﹤0.01% 1362
2025
Q1
Sell
-5,099
Closed -$280K 1516
2024
Q4
$280K Buy
+5,099
New +$258K ﹤0.01% 1308
2024
Q3
Sell
-4,923
Closed -$226K 1449
2024
Q2
$226K Sell
4,923
-119
-2% -$5.61K ﹤0.01% 1279
2024
Q1
$262K Buy
+5,042
New +$221K ﹤0.01% 1223

Other funds holding VCEL

Park Avenue Securities's VCEL Position: Q2 2026 in Review

Park Avenue Securities opened a new position in Vericel Corp (VCEL) in Q2 2026: 5,920 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #1582 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in VCEL as recently as Q2 2025.

Park Avenue Securities first reported a position in VCEL in Q1 2024 and has held it in 5 quarters since. The position peaked at $280K in Q4 2024. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Park Avenue Securities held 5,920 shares of Vericel Corp worth $263K as of Q2 2026.
  • Vericel Corp was a new Park Avenue Securities position in Q2 2026.
  • Vericel Corp made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1582 holding.
  • Park Avenue Securities first reported a position in Vericel Corp in Q1 2024 and has held it in 5 quarters since.
  • Park Avenue Securities's Vericel Corp position peaked at $280K in Q4 2024.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.